NSE BSE
infinium pharmachem ltd stock

INFINIUM PHARMACHEM LTD Share Price

- - (%)
- NSE: INFINIUM

INFINIUM PHARMACHEM LTD Share Price Update

As of the latest trading session, INFINIUM PHARMACHEM LTD share price is currently at 223.3, which is up by 0.35 from its previous closing. Today, the stock has fluctuated between 220.60 and 225.75. Over the past year, INFINIUM PHARMACHEM LTD has achieved a return of 61.73 %. In the last month alone, the return has been 3.13 %. Read More...

INFINIUM PHARMACHEM LTD Performance

Day Range

Low220.60 High225.75
227.15

52 Week Range

Low 140.00 High 315.70
227.15

INFINIUM PHARMACHEM LTD Share Price

15036

INFINIUM

img img img img
No Data Available

Open Price

222.95

Prev. Close

222.95

Volume (Shares)

6500.00

Total traded value

14.76

Upper Circuit

267.50

Lower Circuit

178.40

Note: The current prices & values are delayed, Login to your account for live updates.

INFINIUM PHARMACHEM LTD Fundamentals


(Standalone)

Market Cap (Cr) 113.50
PE Ratio (TTM) 28.50
Book Value / Share 41.50
Beta 0.10
ROE 53.43%
EPS (TTM) 7.97
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.00

INFINIUM PHARMACHEM LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 122.36
Operating Expense 109.13
Net Profit 11.09
Net Profit Margin (%) 9.06
Earnings Per Share (EPS) 7.97
EBITDA 19.05
Effective Tax Rate (%) 25.37
Particulars MAR 2023 (Values in Cr)
Revenue 101.31
Operating Expense 90.39
Net Profit 9.15
Net Profit Margin (%) 9.03
Earnings Per Share (EPS) 18.00
EBITDA 16.55
Effective Tax Rate (%) 25.44
Particulars MAR 2022 (Values in Cr)
Revenue 74.04
Operating Expense 67.56
Net Profit 5.50
Net Profit Margin (%) 7.42
Earnings Per Share (EPS) 54.13
EBITDA 9.65
Effective Tax Rate (%) 25.64
Particulars MAR 2021 (Values in Cr)
Revenue 54.56
Operating Expense 51.41
Net Profit 2.72
Net Profit Margin (%) 4.98
Earnings Per Share (EPS) 26.75
EBITDA 5.53
Effective Tax Rate (%) 27.65
Particulars MAR 2020 (Values in Cr)
Revenue 36.04
Operating Expense 35.22
Net Profit 1.02
Net Profit Margin (%) 2.83
Earnings Per Share (EPS) 10.01
EBITDA 3.20
Effective Tax Rate (%) 26.61
Particulars MAR 2023 (Values in Cr)
Book Value / Share 44.39
ROE % 55.06
ROCE % 36.74
Total Debt to Total Equity 1.45
EBITDA Margin 15.23
Particulars MAR 2022 (Values in Cr)
Book Value / Share 128.88
ROE % 66.43
ROCE % 38.89
Total Debt to Total Equity 1.64
EBITDA Margin 11.06
Particulars MAR 2021 (Values in Cr)
Book Value / Share 69.09
ROE % 48.40
ROCE % 32.17
Total Debt to Total Equity 1.72
EBITDA Margin 7.91
Particulars MAR 2020 (Values in Cr)
Book Value / Share 41.78
ROE % 20.47
ROCE % 18.92
Total Debt to Total Equity 2.08
EBITDA Margin 7.88
Particulars MAR 2023 (Values in Cr)
Book Value / Share 42.69
ROE % 53.43
ROCE % 36.86
Total Debt to Total Equity 1.42
EBITDA Margin 16.34
Particulars MAR 2022 (Values in Cr)
Book Value / Share 123.45
ROE % 56.12
ROCE % 34.43
Total Debt to Total Equity 1.69
EBITDA Margin 13.03
Particulars MAR 2021 (Values in Cr)
Book Value / Share 69.31
ROE % 47.85
ROCE % 31.75
Total Debt to Total Equity 1.70
EBITDA Margin 10.14
Particulars MAR 2020 (Values in Cr)
Book Value / Share 42.46
ROE % 23.61
ROCE % 19.88
Total Debt to Total Equity 2.05
EBITDA Margin 8.88
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.98
Total Assets 70.61
Total Liabilities 70.61
Total Equity 23.78
Share Outstanding 5083060
Price to Book Ratio 0.00
Return on Assets (%) 13.43
Return on Capital (%) 17.9
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.45
Total Assets 58.99
Total Liabilities 58.99
Total Equity 13.92
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 10.34
Return on Capital (%) 16.76
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.98
Total Assets 34.18
Total Liabilities 34.18
Total Equity 7.21
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 7.97
Return on Capital (%) 15.37
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.85
Total Assets 22.44
Total Liabilities 22.44
Total Equity 4.34
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 4.16
Return on Capital (%) 7.07
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.31
Total Assets 60.41
Total Liabilities 60.41
Total Equity 21.69
Share Outstanding 5083060
Price to Book Ratio 0.00
Return on Assets (%) 15.14
Return on Capital (%) 19.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.54
Total Assets 49.05
Total Liabilities 49.05
Total Equity 12.54
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 11.21
Return on Capital (%) 15.69
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.23
Total Assets 30.80
Total Liabilities 30.80
Total Equity 7.04
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 8.82
Return on Capital (%) 15.49
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 20.58
Total Liabilities 20.58
Total Equity 4.31
Share Outstanding 1016612
Price to Book Ratio 0.00
Return on Assets (%) 4.94
Return on Capital (%) 7.72
Particulars MAR 2023 (Values in Cr)
Net Income 12.95
Cash from Operations 11.70
Cash from Investing -4.95
Cash from Financing -3.10
Net change in Cash 0.52
Free Cash Flow 19.17
Particulars MAR 2022 (Values in Cr)
Net Income 8.63
Cash from Operations 13.75
Cash from Investing -6.63
Cash from Financing -1.70
Net change in Cash 3.46
Free Cash Flow 18.47
Particulars MAR 2023 (Values in Cr)
Net Income 12.26
Cash from Operations 10.44
Cash from Investing -2.58
Cash from Financing -2.99
Net change in Cash 1.77
Free Cash Flow 15.09
Particulars MAR 2022 (Values in Cr)
Net Income 7.40
Cash from Operations 11.04
Cash from Investing -7.17
Cash from Financing -1.65
Net change in Cash 0.30
Free Cash Flow 15.74
Particulars MAR 2021 (Values in Cr)
Net Income 3.75
Cash from Operations 7.86
Cash from Investing -4.59
Cash from Financing -1.12
Net change in Cash 1.10
Free Cash Flow 12.46
Particulars MAR 2020 (Values in Cr)
Net Income 1.38
Cash from Operations 2.70
Cash from Investing -1.07
Cash from Financing -1.22
Net change in Cash 0.01
Free Cash Flow 3.80
Company Name Price P/E P/B Market Cap 52 Week Low/High
INFINIUM PHARMACHEM LTD 227.15 27.97 5.37 316.10 140.00 / 315.70
BLISS GVS PHARMA LTD 110.15 12.05 1.19 1155.28 77.65 / 148.95
CIPLA LTD 1485.15 28.17 4.49 119928.54 1028.00 / 1581.70
FERMENTA BIOTECH LIMITED 229.35 0.00 2.33 675.00 137.10 / 262.00
GLAXOSMITHKLINE PHARMA LT 2570.70 66.32 24.49 43549.21 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
INFINIUM PHARMACHEM LTD 227.15 28.50 5.47 316.10 140.00 / 315.70
AMRUTAJAN HEALTH LTD 738.70 47.47 7.40 2135.63 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6349.65 106.48 22.29 15874.13 3730.00 / 7550.00
BLISS GVS PHARMA LTD 110.15 15.17 1.16 1155.28 77.65 / 148.95
ABBOTT INDIA LIMITED 27407.65 48.49 15.74 58241.26 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 229.20
  • 26 Days 228.10
  • 10 Days 229.90
  • 50 Days 225.70
  • 12 Days 229.20
  • 100 Days 227.40
  • 20 Days 227.20
  • 200 Days 290.10
227.55
PIVOT
First Resistance 230.10
Second Resistance 233.25
Third Resistance 235.80
First Support 224.40
Second Support 221.85
Third Support 218.70
RSI 58.04
MACD 1.09
Commodity Channel Index (CCI) -5.88
ADX 19.40
Williams % R -73.57

Over 1 Month

down

3.13

Over 3 Months

down

3.25

Over 6 Months

down

-2.71

Over 1 Year

down

61.73

Over 3 Years

down

0.00

Over 5 Years

down

0.00

INFINIUM PHARMACHEM LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

INFINIUM PHARMACHEM LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
26.94
Promoter Holdings
73.05
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Pravin Bhadabhai Madhani Shareholding of Promoter and Promoter Group 1901840.0 13.67
Sanjaykumar Viththalbhai Patel Shareholding of Promoter and Promoter Group 1598000.0 11.48
Bhadabhai Kacharabhai Madhani Shareholding of Promoter and Promoter Group 1492720.0 10.73
Lavjibhai Ramjibhai Chikhaliya Shareholding of Promoter and Promoter Group 1184890.0 8.51
Varshaben Pravinbhai Madhani Shareholding of Promoter and Promoter Group 1145840.0 8.23
Mitesh Lavjibhai Chikhaliya Shareholding of Promoter and Promoter Group 744360.0 5.35
Daxa Sanjaykumar Patel Shareholding of Promoter and Promoter Group 573000.0 4.12
Bharat Khodabhai Madhani Shareholding of Promoter and Promoter Group 542660.0 3.9
Shardaben Lavjibhai Chikhaliya Shareholding of Promoter and Promoter Group 311620.0 2.24
Dipen Babulal Dobariya Public Shareholding 297500.0 2.14
Vinitkumar Maheshkumar Dobariya Public Shareholding 286500.0 2.06
Mignesh Lavjibhai Chikhaliya Shareholding of Promoter and Promoter Group 226660.0 1.63
Patel Bhupesh Vahalabhai Public Shareholding 142000.0 1.02
Piyush Viththalbhai Chikhaliya Shareholding of Promoter and Promoter Group 125880.0 0.9
Urvishaben Piyushbhai Chikhaliya Shareholding of Promoter and Promoter Group 112910.0 0.81
Vitthalbhai Ramjibhai Chikhalia Shareholding of Promoter and Promoter Group 67220.0 0.48
Varsha Virani Shareholding of Promoter and Promoter Group 37200.0 0.27
Pratikshaben Lavjibhai Chikhaliya Shareholding of Promoter and Promoter Group 37000.0 0.27
Krupaben Miteshbhai Chikhaliya Shareholding of Promoter and Promoter Group 37000.0 0.27
Manjulaben Vitthalbhai Chikhalia Shareholding of Promoter and Promoter Group 27320.0 0.2

INFINIUM PHARMACHEM LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
2023-09-13 2023-09-13 1:1
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About INFINIUM PHARMACHEM LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by INFINIUM PHARMACHEM LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Infinium Pharmachem Ltd?

Answer Field

The share price of Infinium Pharmachem Ltd for NSE is ₹ 223.3 and for BSE is ₹ 0.00.

What is the Market Cap of Infinium Pharmachem Ltd?

Answer Field

The market cap of Infinium Pharmachem Ltd for NSE is ₹ 1,13.50 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Infinium Pharmachem Ltd?

Answer Field

The 52 Week High and Low of Infinium Pharmachem Ltd for NSE is ₹ 315.70 and ₹ 140.00 and for BSE is ₹ 0.00 and ₹ 0.00.

How to Buy Infinium Pharmachem Ltd share?

Answer Field

You can trade in Infinium Pharmachem Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Infinium Pharmachem Ltd?

Answer Field

The 1 year returns on the stock has been 61.73%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader